Trial Profile
Efficacy of ticagrelor versus clopidogrel stratified by estimated glomerular filtration rate (eGFR) in unselected cohort of patients with acute myocardial infarction: A SWEDEHEART registry study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Apr 2018
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin; Clopidogrel
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 09 Apr 2018 Results published in the AstraZeneca Media Release
- 04 Apr 2018 New trial record
- 24 Mar 2018 Results published in the Heart